Effect of Mother DHA Supplementation on Term Newborn.

NCT01947426 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2013-09-20

No results posted yet for this study

Summary

In the present study, we evaluate the effect of the mother suplementación with DHA during the gestation and lactation on diverse aspects of the development of newborn. The effect on the oxidative stress, inflammatory signaling, bone turnover and piscomotor and visual development was studied. Women will in the sixth month of pregnancy, consume a diet balanced during last 3 months of pregnancy and the whole lactation. In addition the women will divide in two groups: one will receive a supplement of docosahexaenoic acid (DHA) to evaluate the effects on the development of the newborn child; whereas another group will receive a placebo. Different samples of blood of the mother and of mother milk will be taken and we will correlating her lipidic profile with the brain development of the newborn child, evaluated by different tests.

Conditions

Interventions

DIETARY_SUPPLEMENT

DHA Supplementation

mothers consuming 400 mg of DHA/day and their neonates

DIETARY_SUPPLEMENT

Control (milk without DHA)

mothers consuming placebo product and their neonates

Sponsors & Collaborators

  • Puleva Biotech

    collaborator INDUSTRY
  • Universidad de Granada

    lead OTHER

Principal Investigators

  • Julio J Ochoa · Universidad de Granada

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Max Age
40 Years
Sex
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-04-30
Completion
2011-04-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01947426 on ClinicalTrials.gov